Seketsu Fukuzawa

Find an error

Name:
Organization: The University of Tokyo
Department: Department of Chemistry
Title:
Co-reporter:Seketsu Fukuzawa, Saori Takahashi, Kazuo Tachibana, Shoji Tajima, Isao Suetake
Bioorganic & Medicinal Chemistry 2016 Volume 24(Issue 18) pp:4254-4262
Publication Date(Web):15 September 2016
DOI:10.1016/j.bmc.2016.07.016
Oxidation of 5-methylcytosine (5mC) is catalyzed by ten-eleven translocation (TET) enzymes to produce 5-hydroxymethylcytosine (5hmC) and following oxidative products. The oxidized nucleotides were shown to be the intermediates for DNA demethylation, as the nucleotides are removed by base excision repair system initiated by thymine DNA glycosylase. A simple and accurate method to determine initial oxidation product 5hmC at single base resolution in genomic DNA is necessary to understand demethylation mechanism. Recently, we have developed a new catalytic oxidation reaction using micelle-incarcerated oxidants to oxidize 5hmC to form 5-formylcytosine (5fC), and subsequent bisulfite sequencing can determine the positions of 5hmC in DNA. In the present study, we described the optimization of the catalytic oxidative bisulfite sequencing (coBS-seq), and its application to the analysis of 5hmC in genomic DNA at single base resolution in a quantitative manner. As the oxidation step showed quite low damage on genomic DNA, the method allows us to down scale the sample to be analyzed.
Co-reporter:Seketsu Fukuzawa, Kazuo Tachibana, Shoji Tajima, Isao Suetake
Bioorganic & Medicinal Chemistry Letters 2015 Volume 25(Issue 24) pp:5667-5671
Publication Date(Web):15 December 2015
DOI:10.1016/j.bmcl.2015.11.017
5-Methylcytosine (5mC) is oxidized by ten-eleven translocation (TET) enzymes. This process followed by thymine DNA glycosylase is proposed to be the mechanism for methylcytosine demethylation. 5-Hydroxymethylcytosine (5hmC) is one of the most important key oxidative metabolites in the demethylation process, and therefore, simple and accurate method to determine 5hmC at single base resolution is desired. In the present study, we developed a mild catalytic oxidation of 5-hmC using micelle incarcerated oxidants that enables to determine the position of 5hmC at single base resolution.
Co-reporter:Dr. Haruhiko Ehara;Marie Makino;Dr. Koichiro Kodama; Dr. Keiichi Konoki;Dr. Takuhiro Ito;Dr. Shun-ichi Sekine;Dr. Seketsu Fukuzawa; Dr. Shigeyuki Yokoyama; Dr. Kazuo Tachibana
ChemBioChem 2015 Volume 16( Issue 10) pp:1435-1439
Publication Date(Web):
DOI:10.1002/cbic.201500141

Abstract

Okadaic acid (OA) is a marine polyether cytotoxin that was first isolated from the marine sponge Halichondria okadai. OA is a potent inhibitor of protein serine/threonine phosphatases (PP) 1 and 2A, and the structural basis of phosphatase inhibition has been well investigated. However, the role and mechanism of OA retention in the marine sponge have remained elusive. We have solved the crystal structure of okadaic acid binding protein 2.1 (OABP2.1) isolated from H. okadai; it has strong affinity for OA and limited sequence homology to other proteins. The structure revealed that OABP2.1 consists of two α-helical domains, with the OA molecule deeply buried inside the protein. In addition, the global fold of OABP2.1 was unexpectedly similar to that of aequorin, a jellyfish photoprotein. The presence of structural homologues suggested that, by using similar protein scaffolds, marine invertebrates have developed diverse survival systems adapted to their living environments.

Co-reporter:Hironori Inoue, Daisuke Hidaka, Seketsu Fukuzawa, Kazuo Tachibana
Bioorganic & Medicinal Chemistry Letters 2014 Volume 24(Issue 2) pp:508-509
Publication Date(Web):15 January 2014
DOI:10.1016/j.bmcl.2013.12.032
The marine alkaloid, norzoanthamine, is considered to be a promising drug for osteoporosis treatment. Due to its rarity and complicated structure, a practical supply method must be developed. Here, we designed a truncated norzoanthamine, which has two-thirds of the original structure, and found that it exhibited similar collagen protection activity.
Co-reporter:Hironori Inoue, Kazuho Tokita, Seketsu Fukuzawa, Kazuo Tachibana
Bioorganic & Medicinal Chemistry 2014 22(13) pp: 3455-3464
Publication Date(Web):
DOI:10.1016/j.bmc.2014.04.040
Co-reporter:Kazuya Yamada, Haruki Kuriyama, Toshiaki Hara, Michio Murata, Raku Irie, Yanit Harntaweesup, Masayuki Satake, Seketsu Fukuzawa, Kazuo Tachibana
Bioorganic & Medicinal Chemistry 2014 22(14) pp: 3773-3780
Publication Date(Web):
DOI:10.1016/j.bmc.2014.04.044
Co-reporter:Takahisa Genji;Kazuo Tachibana
Marine Biotechnology 2010 Volume 12( Issue 1) pp:81-87
Publication Date(Web):2010 February
DOI:10.1007/s10126-009-9202-5
The role of the marine alkaloid, norzoanthamine, in the colonial zoanthid Zoanthus sp. was previously unknown. High concentrations of norzoanthamine are present in the epidermal tissue of Zoanthus sp., as determined using protonated molecular ion peak mapping of norzoanthamine by matrix-assisted laser desorption/ionization mass spectrometry and high-performance liquid chromatography quantification. Sodium dodecylsulfate polyacrylamide gel electrophoresis experiments indicate that norzoanthamine increases the resistance of collagen to damage from UV light, probably not via UV light absorption, but by strengthening collagen itself, thus suggesting that collagen strengthening may be the function of norzoanthamine in Zoanthus sp.
Co-reporter:Masaru Kinugawa
Journal of Bone and Mineral Metabolism 2009 Volume 27( Issue 3) pp:303-314
Publication Date(Web):2009 May
DOI:10.1007/s00774-009-0049-7
Bone is composed of mineralized collagen fibrils. A marine alkaloid, norzoanthamine, accelerates the formation of a collagen–hydroxyapatite composite and enhances collagen release from an immobilized matrix vesicle model. Norzoanthamine recognizes a peptide chain nonspecifically and stabilizes its secondary structure, and collagen has polyvalent binding sites for norzoanthamine. This collagen–norzoanthamine supramolecular association is considered to be one of the most significant modes of action for enhancement of bone formation. The facts that norzoanthamine is nontoxic and that it has a collagen protective activity indicate that it may provide significant therapeutic benefits. In particular, it may be a promising drug candidate for osteoporosis treatment and prevention. Interestingly, norzoanthamine suppressed the proteolysis of not only collagen but also elastin and bovine serum albumin, so it apparently has a universal protective effect of guarding extracellular matrix proteins from degradation. This result suggests that norzoanthamine protect skeletal proteins in the host animal body from external stresses and possibly enhance survival.
Co-reporter:Koichiro Kodama Dr.;Hiroshi Nakayama Dr.;Kensaku Sakamoto Dr.;Takanori Kigawa Dr.;Takashi Yabuki Dr.;Natsuko Matsuda;Mikako Shirouzu Dr.;Koji Takio Dr.;Shigeyuki Yokoyama ;Kazuo Tachibana
ChemBioChem 2007 Volume 8(Issue 2) pp:
Publication Date(Web):29 DEC 2006
DOI:10.1002/cbic.200600432

A new carbon–carbon bond has been regioselectively introduced into a target position (position 32 or 174) of the Ras protein by two types of organopalladium reactions (Mizoroki–Heck and Sonogashira reactions). Reaction conditions were screened by using a model peptide, and the stability of the Ras protein under the reaction conditions was examined by using the wild-type Ras protein. Finally, the iF–Ras proteins containing a 4-iodo-L-phenylalanine residue were subjected to organopalladium reactions with vinylated or propargylated biotin. Site-specific biotinylations of the Ras protein were confirmed by Western blot and LC-MS/MS.

Co-reporter:Koichiro Kodama Dr.;Hiroshi Nakayama Dr.;Takanori Kigawa Dr.;Kensaku Sakamoto Dr.;Takashi Yabuki Dr.;Natsuko Matsuda;Mikako Shirouzu Dr.;Koji Takio Dr.;Kazuo Tachibana ;Shigeyuki Yokoyama
ChemBioChem 2007 Volume 8(Issue 2) pp:
Publication Date(Web):10 JAN 2007
DOI:10.1002/cbic.200790002
Co-reporter:Koichiro Kodama Dr.;Kensaku Sakamoto  Dr.;Hiroshi Nakayama Dr.;Takanori Kigawa ;Takashi Yabuki;Natsuko Matsuda;Mikako Shirouzu Dr.;Koji Takio Dr.;Kazuo Tachibana;Shigeyuki Yokoyama
ChemBioChem 2006 Volume 7(Issue 10) pp:
Publication Date(Web):12 SEP 2006
DOI:10.1002/cbic.200600137

An Escherichia coli suppressor tRNAPhe (tRNAPheCUA) was misacylated with 4-iodo-L-phenylalanine by using the A294G phenylalanyl–tRNA synthetase mutant (G294-PheRS) from E. coli at a high magnesium-ion concentration. The preacylated tRNA was added to an E. coli cell-free system and a Ras protein that contained the 4-iodo-L-phenylalanine residue at a specific target position was synthesized. Site-specific incorporation of 4-iodo-L-phenylalanine was confirmed by using LC–MS/MS. Free tRNAPheCUA was not aminoacylated by aminoacyl–tRNA synthetases (aaRSs) present in the E. coli cell-free system. Our approach will find wide application in protein engineering since an aryl iodide tag on proteins can be used for site-specific functionalization of proteins.

Co-reporter:Koichiro Kodama Dr.;Hiroshi Nakayama Dr.;Takanori Kigawa Dr.;Kensaku Sakamoto Dr.;Takashi Yabuki Dr.;Natsuko Matsuda;Mikako Shirouzu Dr.;Koji Takio Dr.;Kazuo Tachibana ;Shigeyuki Yokoyama
ChemBioChem 2006 Volume 7(Issue 1) pp:
Publication Date(Web):5 JAN 2006
DOI:10.1002/cbic.200690000
Co-reporter:Koichiro Kodama Dr.;Hiroshi Nakayama Dr.;Takanori Kigawa Dr.;Kensaku Sakamoto Dr.;Takashi Yabuki Dr.;Natsuko Matsuda;Mikako Shirouzu Dr.;Koji Takio Dr.;Kazuo Tachibana ;Shigeyuki Yokoyama
ChemBioChem 2006 Volume 7(Issue 1) pp:
Publication Date(Web):24 NOV 2005
DOI:10.1002/cbic.200500290

Palladium-catalyzed reactions have contributed to the advancement of many areas of organic chemistry, in particular, the synthesis of organic compounds such as natural products and polymeric materials. In this study, we have used a Mizoroki–Heck reaction for site-specific carbon–carbon bond formation in the Ras protein. This was performed by the following two steps: 1) the His6-fused Ras protein containing 4-iodo-L-phenylalanine at position 32 (iF32-Ras-His) was prepared by genetic engineering and 2) the aryl iodide group on the iF32-Ras-His was coupled with vinylated biotin in the presence of a palladium catalyst. The biotinylation was confirmed by Western blotting and liquid chromatography–mass spectrometry (LC-MS). The regioselectivity of the Mizoroki–Heck reaction was furthermore confirmed by LC-MS/MS analysis. However, in addition to the biotinylated product (bF32-Ras-His), a dehalogenated product (F32-Ras-His) was detected by LC-MS/MS. This dehalogenation resulted from the undesired termination of the Mizoroki–Heck reaction due to steric and electrostatic hindrance around residue 32. The biotinylated Ras showed binding activity for the Ras-binding domain as its downstream target, Raf-1, with no sign of decomposition. This study is the first report of an application of organometallic chemistry in protein chemistry.

3H-1,2,4-Triazole-3,5(4H)-dione,4-[2-(3,4-dihydro-6,7-dimethoxy-4-methyl-3-oxo-2-quinoxalinyl)ethyl]-
yessotoxin
Cyclohexanepropanoicacid, 1-methyl-2-oxo-, methyl ester, (1R)-
4H,10H-9a,13-Epoxy-15a,7-(epoxyethano)azepino[1,2-a]naphtho[2,1-g]quinoline-4,6,18(6aH)-trione, 1,4a,5,7,7a,8,9,11,12,13,14,16,16a,16b-
FLUORESCEIN-5-MALEIMIDE
1H-Pyrrole-2,5-dione,1-[7-(dimethylamino)-4-methyl-2-oxo-2H-1-benzopyran-3-yl]-
Sulfite, hydrogen(8CI,9CI)
SODIUM PHOSPHATE
Guanosine5'-(tetrahydrogen triphosphate)
2-Hydroxy-2-azaadaMantane